Genomics

Dataset Information

0

CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I


ABSTRACT: CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I

PROVIDER: PRJEB82105 | ENA |

REPOSITORIES: ENA

Dataset's files

Source:
Action DRS
ERR13927582_1.fastq.gz Fastqsanger.gz
ERR13927582_2.fastq.gz Fastqsanger.gz
ERR13927583_1.fastq.gz Fastqsanger.gz
ERR13927583_2.fastq.gz Fastqsanger.gz
ERR13927584_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 10

Similar Datasets

| PRJNA598123 | ENA
2019-12-31 | GSE142722 | GEO
| PRJNA598121 | ENA
| PRJNA598127 | ENA
2019-12-31 | GSE142721 | GEO
2019-12-31 | GSE142704 | GEO
2019-12-31 | GSE142782 | GEO
| PRJNA598328 | ENA
2021-11-20 | GSE189135 | GEO
| S-EPMC5936814 | biostudies-literature